Literature DB >> 10750149

Unmasking effect of propafenone on the concealed form of the Brugada phenomenon.

A Matana1, V Goldner, K Stanić, Z Mavrić, L Zaputović, Z Matana.   

Abstract

A case report of a patient with frequent ventricular premature beats but with an otherwise normal ECG and no structural heart disease. Propafenone in therapeutical doses unmasked the ECG picture of the Brugada phenomenon.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10750149     DOI： 10.1111/j.1540-8159.2000.tb06774.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN： 0147-8389            Impact factor:   1.976


  13 in total

1.  Quantitative modelling of interaction of propafenone with sodium channels in cardiac cells.

Authors:  M Pásek; J Simurda
Journal:  Med Biol Eng Comput       Date:  2004-03       Impact factor: 2.602

Review 2.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

Review 3.  Mechanisms Underlying the Actions of Antidepressant and Antipsychotic Drugs That Cause Sudden Cardiac Arrest.

Authors:  Serge Sicouri; Charles Antzelevitch
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

Review 4.  J-wave syndromes: Brugada and early repolarization syndromes.

Authors:  Charles Antzelevitch; Gan-Xin Yan
Journal:  Heart Rhythm       Date:  2015-04-11       Impact factor: 6.343

Review 5.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

6.  Novel Therapeutic Strategies for the Management of Ventricular Arrhythmias Associated with the Brugada Syndrome.

Authors:  Bence Patocskai; Charles Antzelevitch
Journal:  Expert Opin Orphan Drugs       Date:  2015-05-13       Impact factor: 0.694

Review 7.  The Brugada syndrome.

Authors:  P Brugada; R Brugada; J Brugada
Journal:  Curr Cardiol Rep       Date:  2000-11       Impact factor: 2.931

Review 8.  Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org).

Authors:  Pieter G Postema; Christian Wolpert; Ahmad S Amin; Vincent Probst; Martin Borggrefe; Dan M Roden; Silvia G Priori; Hanno L Tan; Masayasu Hiraoka; Josep Brugada; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2009-07-08       Impact factor: 6.343

9.  Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.

Authors:  Hector M Barajas-Martínez; Dan Hu; Jonathan M Cordeiro; Yuesheng Wu; Richard J Kovacs; Henry Meltser; Hong Kui; Burashnikov Elena; Ramon Brugada; Charles Antzelevitch; Robert Dumaine
Journal:  Circ Res       Date:  2008-07-03       Impact factor: 17.367

Review 10.  Brugada Syndrome: Clinical, Genetic, Molecular, Cellular, and Ionic Aspects.

Authors:  Charles Antzelevitch; Bence Patocskai
Journal:  Curr Probl Cardiol       Date:  2015-06-11       Impact factor: 5.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.